Your browser doesn't support javascript.
loading
Association of technologically assisted integrated care with clinical outcomes in type 2 diabetes in Hong Kong using the prospective JADE Program: A retrospective cohort analysis.
Lim, Lee-Ling; Lau, Eric S H; Ozaki, Risa; Chung, Harriet; Fu, Amy W C; Chan, Wendy; Kong, Alice P S; Ma, Ronald C W; So, Wing-Yee; Chow, Elaine; Cheung, Kitty K T; Yau, Tiffany; Chow, C C; Lau, Vanessa; Yue, Rebecca; Ng, Shek; Zee, Benny; Goggins, William; Oldenburg, Brian; Clarke, Philip M; Lau, Maggie; Wong, Rebecca; Tsang, C C; Gregg, Edward W; Wu, Hongjiang; Tong, Peter C Y; Ko, Gary T C; Luk, Andrea O Y; Chan, Juliana C N.
Afiliação
  • Lim LL; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR, China.
  • Lau ESH; Asia Diabetes Foundation, Shatin, Hong Kong SAR, China.
  • Ozaki R; Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
  • Chung H; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR, China.
  • Fu AWC; Asia Diabetes Foundation, Shatin, Hong Kong SAR, China.
  • Chan W; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR, China.
  • Kong APS; Asia Diabetes Foundation, Shatin, Hong Kong SAR, China.
  • Ma RCW; Asia Diabetes Foundation, Shatin, Hong Kong SAR, China.
  • So WY; Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR, China.
  • Chow E; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR, China.
  • Cheung KKT; Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR, China.
  • Yau T; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR, China.
  • Chow CC; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR, China.
  • Lau V; Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR, China.
  • Yue R; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR, China.
  • Ng S; Hospital Authority Head Office, Hong Kong SAR, China.
  • Zee B; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR, China.
  • Goggins W; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR, China.
  • Oldenburg B; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR, China.
  • Clarke PM; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR, China.
  • Lau M; Asia Diabetes Foundation, Shatin, Hong Kong SAR, China.
  • Wong R; Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR, China.
  • Tsang CC; Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR, China.
  • Gregg EW; Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR, China.
  • Wu H; Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR, China.
  • Tong PCY; Centre for Health Policy, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
  • Ko GTC; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
  • Luk AOY; Alice Ho Miu Ling Nethersole Hospital, Tai Po, Hong Kong SAR, China.
  • Chan JCN; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR, China.
PLoS Med ; 17(10): e1003367, 2020 10.
Article em En | MEDLINE | ID: mdl-33007052
ABSTRACT

BACKGROUND:

Diabetes outcomes are influenced by host factors, settings, and care processes. We examined the association of data-driven integrated care assisted by information and communications technology (ICT) with clinical outcomes in type 2 diabetes in public and private healthcare settings. METHODS AND

FINDINGS:

The web-based Joint Asia Diabetes Evaluation (JADE) platform provides a protocol to guide data collection for issuing a personalized JADE report including risk categories (1-4, low-high), 5-year probabilities of cardiovascular-renal events, and trends and targets of 4 risk factors with tailored decision support. The JADE program is a prospective cohort study implemented in a naturalistic environment where patients underwent nurse-led structured evaluation (blood/urine/eye/feet) in public and private outpatient clinics and diabetes centers in Hong Kong. We retrospectively analyzed the data of 16,624 Han Chinese patients with type 2 diabetes who were enrolled in 2007-2015. In the public setting, the non-JADE group (n = 3,587) underwent structured evaluation for risk factors and complications only, while the JADE (n = 9,601) group received a JADE report with group empowerment by nurses. In a community-based, nurse-led, university-affiliated diabetes center (UDC), the JADE-Personalized (JADE-P) group (n = 3,436) received a JADE report, personalized empowerment, and annual telephone reminder for reevaluation and engagement. The primary composite outcome was time to the first occurrence of cardiovascular-renal diseases, all-site cancer, and/or death, based on hospitalization data censored on 30 June 2017. During 94,311 person-years of follow-up in 2007-2017, 7,779 primary events occurred. Compared with the JADE group (136.22 cases per 1,000 patient-years [95% CI 132.35-140.18]), the non-JADE group had higher (145.32 [95% CI 138.68-152.20]; P = 0.020) while the JADE-P group had lower event rates (70.94 [95% CI 67.12-74.91]; P < 0.001). The adjusted hazard ratios (aHRs) for the primary composite outcome were 1.22 (95% CI 1.15-1.30) and 0.70 (95% CI 0.66-0.75), respectively, independent of risk profiles, education levels, drug usage, self-care, and comorbidities at baseline. We reported consistent results in propensity-score-matched analyses and after accounting for loss to follow-up. Potential limitations include its nonrandomized design that precludes causal inference, residual confounding, and participation bias.

CONCLUSIONS:

ICT-assisted integrated care was associated with a reduction in clinical events, including death in type 2 diabetes in public and private healthcare settings.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Prestação Integrada de Cuidados de Saúde / Diabetes Mellitus Tipo 2 Tipo de estudo: Etiology_studies / Evaluation_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies País/Região como assunto: Asia Idioma: En Revista: PLoS Med Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Prestação Integrada de Cuidados de Saúde / Diabetes Mellitus Tipo 2 Tipo de estudo: Etiology_studies / Evaluation_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies País/Região como assunto: Asia Idioma: En Revista: PLoS Med Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China